The 3-point bending test, nanoindentation, FTIR, and cyclic reference point indentation (cRPI) measured the changes in bone strength and material composition
Glutathione does not accumulate as a toxin in healthy individuals
Phase 2 trial (NEJM 2023) reported 24.2% mean weight loss at 48 weeks with 12 mg/week retatrutide, with gastrointestinal adverse events rising sharply at the 8 mg and 12 mg doses
Parker WD Jr., Parks JK, Filley CM, Kleinschmidt-DeMasters BK
Epithalon is not an FDA-approved drug, but it is: For safety and quality, Epithalon should be sourced through a qualified healthcare provider
GCDC in the therapeutic group was elevated relative to control although not significantly